LITTLE FALLS, N.J., March 2 /PRNewswire-FirstCall/ -- Cantel Medical Corp. (NYSE: CMN) will release the results for its second quarter ended January 31, 2010 on Tuesday, March 9 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET. Participating in the call will be Charles M. Diker, Chairman; Andrew A. Krakauer, President and CEO; Seth R. Segel, Executive Vice President; Craig A. Sheldon, Senior Vice President, CFO and Treasurer; and Roy K. Malkin, President of Minntech Corporation, a Cantel subsidiary.
To participate in the conference call, dial (877) 407-8035 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Tuesday, March 9, 2010 at 2:00 PM through midnight on March 16, 2010 by dialing (877) 660-6853 and using pass code # 286 and conference ID # 346358.
The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=156065. A replay of the webcast will be available on Vcall for 30 days.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Cantel's products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. Cantel also provides technical maintenance for its products and offers compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at http://www.cantelmedical.com.
SOURCE Cantel Medical Corp.Back to top
|SOURCE Cantel Medical Corp.|
Copyright©2010 PR Newswire.
All rights reserved